Current status and challenges of stem cell-based therapy for the treating of glioblastoma multiforme Stem cell-based therapy treating glioblastoma multiforme
Glioblastoma (GB) is one of the most malignant types of central nervous system tumours, classified as grade IV by the World Health Organization. Despite the therapeutic advances, the prognosis is ominous, with a median survival of about 12–15 months post diagnosis. Although therapeutic options avail...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Serie: | Hematology/Oncology and Stem Cell Therapy |
| Soggetti: | |
| Accesso online: | https://journals.lww.com/10.1016/j.hemonc.2020.08.001 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|